More than 200 cyclists including injured veterans and their supporters will set off Monday, Apr 16, on the Ride 2 Recovery Texas Challenge sponsored by UnitedHealthcare, a seven-day, 350-mile ride from San Antonio to Arlington.
Texas Challenge cyclists will start their journey at Brooke Army Medical Center’s Center for the Intrepid in San Antonio and ride through central Texas with overnight stops in San Marcos, Austin, Ft. Hood, Waco and Cleburne. The ride will conclude in Arlington Saturday, April 21, at Cowboys Stadium.
On Sunday, April, 22, in Arlington, Ride 2 Recovery will stage the first Clay Hunt Memorial Honor Ride, inviting the public to join the participating veterans for a day of cycling. To see daily stops and events along the route or to sign up for the Texas Challenge, visit
The USO will support daily rest stops with a mobile canteen, and the American Legion Family will provide a motorcycle escort and sponsor dinners and community events. The public is encouraged to gather along the daily routes to support the cyclists.
Ride 2 Recovery supports physical and psychological rehabilitation programs for injured veterans, featuring cycling as the core activity. From indoor spinning training at military installations to multiday, long-distance rides, Ride 2 Recovery helps injured veterans heal through the challenge of cycling long distances using hand cycles, recumbents, tandems and traditional road bikes.
“The Ride 2 Recovery Texas Challenge helps support important health programs for men and women who served our country, and we are honored to serve them through this sponsorship,” said Tom Quirk, CEO, UnitedHealthcare Employer & Individual of Texas. “Exercise and rehabilitation services are critically important to help injured veterans enjoy a return to the health and well-being they richly deserve.”
This is the third year that UnitedHealthcare is serving as Ride 2 Recovery’s presenting sponsor, providing financial, in-kind and volunteer support to assist in the rehabilitation of America’s injured veterans.